Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea · Delayed Price · Currency is KRW 76,900
-7,700 (-9.10%)
At close: Apr 9, 2026
Curiox Biosystems Revenue
In the year 2025, Curiox Biosystems had annual revenue of 5.15B KRW with 12.29% growth. Curiox Biosystems had revenue of 1.85B in the quarter ending December 31, 2025, with 93.45% growth.
Revenue
5.15B
Revenue Growth
+12.29%
P/S Ratio
246.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.27T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.15B | 563.91M | 12.29% |
| Dec 31, 2024 | 4.59B | -2.20B | -32.41% |
| Dec 31, 2023 | 6.79B | -449.07M | -6.21% |
| Dec 31, 2022 | 7.24B | 1.71B | 31.04% |
| Dec 31, 2021 | 5.52B | 1.14B | 25.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 114.25B |
| Synergy Innovation | 113.05B |
| Corentec | 100.43B |
| M.I.TECH Co.,Ltd | 67.15B |
| Livsmed | 51.19B |
| BIOBIJOU | 28.49B |
| Finemedix | 9.52B |
| Genolution | 9.40B |